Caenorhabditis elegans LET-381 and DMD-4 control development of the mesodermal HMC endothelial cell
Development · 2025
DOI: 10.1242/dev.204622 ↗At a glance
Journal article in Development, 2025. Written by Nikolaos Stefanakis and 3 co-authors. Institution: Laboratory of Developmental Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA. Major MEDLINE topics: Caenorhabditis elegans, Mesoderm, Forkhead Transcription Factors, Endothelial Cells. Cited 1 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: Rockefeller University, NIH HHS, Leon Levy Foundation.
Abstract (original language)
Endothelial cells form the inner layer of blood vessels and play key roles in circulatory system development and function. A variety of endothelial cell types have been described through gene expression and transcriptome studies; nonetheless, the transcriptional programs that specify endothelial cell fate and maintenance are not well understood. To uncover such regulatory programs, we studied the C. elegans head mesodermal cell (HMC), a non-contractile mesodermal cell bearing molecular and functional similarities to vertebrate endothelial cells. Here, we demonstrate that a Forkhead transcription factor, LET-381, is required for HMC fate specification and maintenance of HMC gene expression. DMD-4, a DMRT transcription factor, acts downstream of and in conjunction with LET-381 to mediate these functions. Independently of LET-381, DMD-4 also represses the expression of genes associated with a different, non-HMC, mesodermal fate. Our studies uncover essential roles for FoxF transcriptional regulators in endothelial cell development and suggest that FoxF co-functioning target transcription factors promote specific non-contractile mesodermal fates.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratory of Developmental Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA.
ORCID profiles: Nikolaos Stefanakis, Shai Shaham
Funding
- Rockefeller University
- NIH HHS
- Leon Levy Foundation
- NINDS NIH HHS
- National Institutes of Health
Cite
APA
Stefanakis, N., Xi, J., Jiang, J., & Shaham, S. (2025). Caenorhabditis elegans LET-381 and DMD-4 control development of the mesodermal HMC endothelial cell. Development. https://doi.org/10.1242/dev.204622
Vancouver
Stefanakis N, Xi J, Jiang J, Shaham S. Caenorhabditis elegans LET-381 and DMD-4 control development of the mesodermal HMC endothelial cell. Development. 2025. doi:10.1242/dev.204622
BibTeX
@article{Stefanakis2025,
author = {Stefanakis, Nikolaos and Xi, Jasmine and Jiang, Jessica and Shaham, Shai},
title = {Caenorhabditis elegans LET-381 and DMD-4 control development of the mesodermal HMC endothelial cell},
journal = {Development},
year = {2025},
doi = {10.1242/dev.204622}
}
EUVIMED